Tag Archives: Venclexta

AbbVie unveils Venclexta data that scored lightning-fast leukemia combination nod

CHICAGO—Last month, partners AbbVie and Roche nabbed a speedy approval for Venclexta and Gazyva in chronic lymphocytic leukemia (CLL). And Tuesday, they rolled out the data that helped get them to the finish line. A phase 3 study presented at the American Society of Clinical Oncology annual meeting showed that in previously untreated patients with both… Read More »